Skip to content

Mental Attention-neuromuscular Training for Children With Developmental Coordination Disorder

Improving Mental Attention, Timing of Muscle Activation and Reactive Balance Control in Children With Developmental Coordination Disorder: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02397161
Enrollment
172
Registered
2015-03-24
Start date
2016-07-31
Completion date
2017-07-31
Last updated
2015-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Coordination Disorder

Brief summary

Objective: To compare the effectiveness of EEG biofeedback mental attention-neuromuscular training (AT-NMT), neuromuscular training (NMT) alone, EEG biofeedback mental attention training (AT) alone, and no intervention for improving reactive balance performance among children with developmental coordination disorder (DCD). Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency.

Detailed description

Hypothesis: The Investigators hypothesize that the reactive balance performance in children with DCD can be best improved by treating both their mental attention and neuromuscular deficits. Objective: To compare the effectiveness of AT-NMT, NMT alone, AT alone, and no intervention for improving reactive balance performance among children with DCD. Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency. Anticipated results and clinical significance: Children with DCD who receive AT-NMT will have the best reactive balance performance outcomes. If the results are positive, this novel training regime can be readily adopted in clinical practice. AT-NMT will improve overall well-being in these children and have positive socio-economic implications such as shorter rehabilitation periods and reduced healthcare costs.

Interventions

OTHEREEG biofeedback mental attention-neuromuscular training

Mental attention training using EEG biofeedback and neuromuscular training using physio-therapeutic exercises

OTHERNeuromuscular training

Neuromuscular training using physio-therapeutic exercises

OTHEREEG biofeedback mental attention training

Mental attention training using EEG biofeedback

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

1. 6 to 9 years old; 2. a formal diagnosis of DCD based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) at a child assessment center; 3. a Bruininks-Oseretsky Test of Motor Proficiency giving a gross motor composite score of ≤42; 4. a Child Behavior Checklist attention problem subscale T score of ≥54.5, indicating an attention deficit; 5. attending a local mainstream school; 6. an intelligence level within the normal range; and 7. no experience in using the Brain Computer Interface system or similar apparatus.

Exclusion criteria

1. a diagnosis of neurological or other movement disorder; 2. any cognitive, psychiatric (comorbid ADHD will not be excluded), congenital, musculoskeletal or cardiopulmonary disorder that can affect motor performance; 3. receiving active therapies or treatments including complementary and alternative medicine; 4. demonstrating excessive disruptive behavior; or 5. those unable to follow instructions adequately.

Design outcomes

Primary

MeasureTime frame
Change in motor control test composite latency scoreBaseline (0 month), post-intervention (3 months), and 3-month follow-up (6 months)

Secondary

MeasureTime frame
Change in EEG mental attention levelBaseline (0 month), post-intervention (3 months), and 3-month follow-up (6 months)
Change in surface EMG lower limb muscle onset latencyBaseline (0 month), post-intervention (3 months), and 3-month follow-up (6 months)

Countries

Hong Kong

Contacts

Primary ContactShirley SM Fong, PT, PhD
smfong@hku.hk+85297090337

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026